Skip to Main Content

ATLANTA — The remarkable ability of CAR-T therapies to eradicate cancer cells from desperately ill patients does not come without serious safety risks, notably the inflammatory storm called cytokine release syndrome and neurological side effects, including confusion and swelling of the brain. Currently, CAR-T therapy is administered in the hospital so admitted patients can be monitored closely for any warning signs. This adds costs to the already expensive treatment.

It also raises a key question: As CAR-T therapy evolves, will it ever become safe enough so patients can be treated and cared for outside the hospital?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.